NCT04769427 is a NA clinical trial of PDO max threads in Nasal Defect, sponsored by DeNova Research.

Who is sponsoring NCT04769427?

NCT04769427 is sponsored by DeNova Research.

What drugs are being tested in NCT04769427?

Interventions in NCT04769427: PDO max threads.

What condition does NCT04769427 study?

NCT04769427 studies Nasal Defect.

Is NCT04769427 still recruiting?

NCT04769427 is currently completed. Last updated 12 October 2021.

Last reviewed 2021-10-12 · How we verify

NCT04769427

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Non-Surgical Rhinoplasty Using PDO Threads

Completed NA Last updated 12 October 2021

What this trial tests

NA trial testing PDO max threads in Nasal Defect in 10 participants. Completed in 10 October 2021.

Timeline

20 January 2021

Primary endpoint
9 June 2021

10 October 2021

Quick facts

Lead sponsor	DeNova Research
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	10
Start date	20 January 2021
Primary completion	9 June 2021
Estimated completion	10 October 2021
Sites	1 location across United States

Drugs / interventions tested

PDO max threads

Conditions studied

Nasal Defect — all drugs for Nasal Defect →

Sponsor

DeNova Research — full company profile →

Who can join

18 and older, any sex, with Nasal Defect. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To determine the effects of absorbable Polydioxanone (PDO) thread non-surgical revision rhinoplasty on first impressions and quality of life (FACE-Q scale) in 10 patients who desire further changes to their nasal tip and/or nasal dorsum

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other DeNova Research trials

Trials by the same sponsor.

NCT05730543 — Ethnic Lip Augmentation With Hyaluronic Acid Filler · Phase 3 · completed
NCT05343559 — First Impressions and Attractiveness Levels of Smiling Individuals With and Without a Mask · completed
NCT05739721 — ZOOM First Impressions · NA · withdrawn
NCT04439825 — Impact of Botox Treatment Into the Upper One Third of the Face an Area on Mood and Self -Appearance Satisfaction · Phase 1 · completed
NCT04162002 — Restylane® Lyft Filler Injection for Hand Rejuvenation on First Impressions · Phase 1 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04769427 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by DeNova Research
Last refreshed: 12 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04769427.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing